In conclusion, the current study is the first to report the highly potent anti-tumour in vitro activity of RG7388 in p53 wt neuroblastoma cells as a single agent, and synergistic activity with conventional chemotherapies routinely used to treat neuroblastoma patients. Here, TP53 is linked to neuroblastoma.